BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8838103)

  • 1. [Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer].
    Kondo M; Takahashi T
    Nihon Rinsho; 1996 Feb; 54(2):492-6. PubMed ID: 8838103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.
    Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T
    Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF2 but not H19 shows loss of imprinting in human glioma.
    Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
    Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
    Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
    Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
    J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
    Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V
    Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.
    Yun K; Fukumoto M; Jinno Y
    Am J Pathol; 1996 Apr; 148(4):1081-7. PubMed ID: 8644850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
    Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
    Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of imprinted genes in Wilms tumors.
    Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R
    Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
    Wu J; Qin Y; Li B; He WZ; Sun ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas.
    Rainho CA; Pontes A; Rogatto SR
    Gynecol Oncol; 1999 Sep; 74(3):375-80. PubMed ID: 10479496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
    Brown KW; Power F; Moore B; Charles AK; Malik KT
    Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
    Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
    Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
    Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
    Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.